ArticleJournal of applied genetics2026
Association of the BoLA-DRB3*12:01 allele with resistance to bovine leukosis virus infection in Crioula Lageana cattle.
Article in Journal of applied genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Enzootic bovine leukosis (EBL) caused by the bovine leukosis virus (BLV) disturbs the immune response in bovines, leading to severe economic losses, with a possible impact on public health. EBL has no treatment or vaccine available, making the identification of genetic polymorphisms related to BLV resistance in locally adapted breeds like Crioula Lageana cattle valuable perspectives. This study aims to determine the presence of the BoLA-DRB3 alleles associated with susceptibility or resistance to BLV in Crioula Lageana cattle. For that, 208 Crioula Lageana bovines, spanning various ages, categories, and sexes, were subjected to blood sampling for DNA extraction for genetic characterization. The PCR targeted the 440-bp fragment of the env gene of the BLV and 284-bp for the alleles of the BoLA-DRB3 gene. The alleles were identified using Sanger sequencing, and the allele amount and frequency were determined by direct counting. For the determination of resistance or susceptibility, firstly the association between each allele and infection by BLV was determined using the chi-square test (p < 0.05), and then it was followed by an odds ratio analysis. The occurrence of BLV was 38.46% (80/208). The DRB3*12:01 allele was associated with resistance to BLV infection (p = 0.035, O.R. = 0.000. The presence of alleles linked to resistance to disease incidence highlights the potential to enhance genetic approaches in formulating management and control strategies for EBL in diverse cattle populations, with potential implications for livestock production, food safety, and public health.
Indexed as
Identifiers
40858974What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.